The G534E polymorphism of the gene encoding the factor VII–activating protease is associated with cardiovascular risk due to increased neointima formation
Open Access
- 4 December 2006
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 203 (13) , 2801-2807
Abstract
The G534E polymorphism (Marburg I [MI]) of factor VII–activating protease (FSAP) is associated with carotid stenosis and cardiovascular disease. We have previously demonstrated that FSAP is present in atherosclerotic plaques and it is a potent inhibitor of vascular smooth muscle proliferation and migration in vitro. The effect of wild-type (WT)- and MI-FSAP on neointima formation in the mouse femoral artery after wire-induced injury was investigated. Local application of WT-FSAP led to a 70% reduction in the neointima formation, and this effect was dependent on the protease activity of FSAP. MI-FSAP did not inhibit neointima formation in vivo. This is due to a reduced proteolytic activity of MI-FSAP, compared to WT-FSAP, toward platelet-derived growth factor BB, a key mediator of neointima development. The inability of MI-FSAP to inhibit vascular smooth muscle accumulation explains the observed linkage between the MI-polymorphism and increased cardiovascular risk. Hence, FSAP has a protective function in the vasculature, and analysis of MI polymorphism is likely to be clinically relevant in restenosis.Keywords
This publication has 13 references indexed in Scilit:
- The hyaluronan-binding protease upregulates ERK1/2 and PI3K/Akt signalling pathways in fibroblasts and stimulates cell proliferation and migrationCellular Signalling, 2005
- Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary InterventionsCirculation, 2005
- Marburg I polymorphism of factor VII–activating protease is associated with idiopathic venous thromboembolismBlood, 2005
- Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP)Biochemical Journal, 2005
- Factor VII activating protease (FSAP) inhibits growth factor‐mediated cell proliferation and migration of vascular smooth muscle cells.The FASEB Journal, 2004
- Drug-Eluting StentsAnnual Review of Medicine, 2004
- Concomitant blockade of platelet-derived growth factor receptors α and β induces intimal atrophy in baboon PTFE graftsJournal of Vascular Surgery, 2004
- The factor VII activating protease G511E (Marburg) variant and cardiovascular riskThrombosis and Haemostasis, 2004
- Marburg I Polymorphism of Factor VII–Activating ProteaseCirculation, 2003
- A Mouse Model of Vascular Injury that Induces Rapid Onset of Medial Cell Apoptosis Followed by Reproducible Neointimal HyperplasiaJournal of Molecular and Cellular Cardiology, 2000